U.S. National Institutes of Heath www.cancer.gov

CDP Home > Research Funded by the Cancer Diagnosis Program > CDP New Grants for Fiscal Year 2002

Research Funded by the Cancer Diagnosis Program

CDP New Grants for Fiscal Year 2002

Resource Related Research Project (R24) Grants Awarded by CDP in Response to RFA CA01-020, Shared Resources for Scientists Not At NCI Funded Cancer Centers

Heffelfinger, Sue C, MD, PhD
Cancer Center Tumor Phenotyping Core
University of Cincinnati, Cincinnati, OH

Henderson, Scott C, PhD
Advanced Microscopy Shared Resource Facility
Mount Sinai School of Medicine of NYU, New York, NY

Mikkelsen, Tom, MD
A Multi-use Glioma Biorepository
Case Western Reserve Univ-Henry Ford HSC, Detroit, MI

Schnitzer, Jan E, MD
Proteomic Resource for Basic & Clinical Cancer Research
Sidney Kimmel Cancer Center, San Diego, CA

Willey, James C, MD
Standardized Gene Expression Core Facility Development
Medical College of Ohio at Toledo, Toledo, OH

R43 Award by CDP in Response to PA 00-018, Bioengineering Nanotechnology Initiative

Szmacinski, Henry K, PhD
Metallic Nanosensor Matrix with Enhanced Fluorescence
Microcosm, Inc, Columbia, MD

R21 Award by CDP in Response to PA 01-010, Exploratory Studies in Cancer Detection, Prognosis and Prediction

This Program Announcement replaces and supersedes two prior Program Announcements, PA-98-022 (Exploratory Studies in Cancer Diagnostics) and PA-98-042 (Exploratory Grants for Correlative Laboratory Studies and Clinical Trials).

Bosron, William F, PhD
CPT11 Activation by Carboxylesterases in Colon Cancer
Indiana Univ-Purdue Univ at Indianapolis, Indianapolis, IN

Diamandis, Eleftherios P, MD
A New Biomarker for Ovarian Cancer Detection
Mount Sinai Hospital (Toronto), Toronto, ON

Ganju-Krishan, Awtar T, PhD
Flow Cytometry to Detect Human Tumor Cells in Body Fluid
University of Miami, Miami, FL

Jiang, Yulei, PhD
Neural Network Prediction of Prostate Cancer Progression
University of Chicago, Chicago, IL

Knoll, Joan H, PhD
Sequence Based FISH Analysis of Philadelphia Chromosomes
Children's Mercy Hospital, Kansas City, MO

Ladner, Robert D, PhD
dUTPase as A Prognostic Marker in Colon Cancer
Univ of Med/Dent NJ-Sch Osteopathic Medicine, Stratford, NJ

Mathur, Subbi P, PhD
Early Diagnosis of Cervical Cancer
Medical University of South Carolina, Charleston, SC

Nieto, Yago, MD
Prognostic Modeling of High-Risk Primary Breast Cancer
University of Colorado Health Sciences Center, Denver, CO

Ornstein, David K, MD
Proteomic Studiy of Androgen Independent Prostate Cancer
University of North Carolina Chapel Hill, Chapel Hill, NC

Ross, Jeffrey, MD
Human RNA Binding Protein as a Cancer Marker
University of Wisconsin Madison, Madison, WI

Tonetti, Debra A, PhD
PKC as a Marker in Tamoxifen Resistant Breast Cancer
University of Illinois at Chicago, Chicago, IL

Wong, David G, DMSc
Molecular Predictors of Oral Premalignancy Progression
University of California Los Angeles, Los Angeles, CA

R01 and R21 Grants Awarded by CDP in Response to PA 01-015, Correlative Studies using Specimens from Multi-Institutional Prevention and Treatment Trials

Plass, Christoph, PhD
DNA Methylation as a Diagnostic Marker in AML
Ohio State University, Columbus, OH

Van Ness, Brian G, PhD
Genetic Polymorphisms in Myeloma
University of Minnesota Twin Cities, Minneapolis, MN

R21 Grants Awarded by CDP in Response to PA 01-030, Exploratory/Developmental Grants for Diagnostic Cancer Imaging

Borejdo, Julian, PhD
Imaging Melanin in Melanocytes
University of North Texas Health Science Center, Fort Worth, TX

R01 and R21 Grants Awarded by CDP in Response to PA 98-099, Correlative Studies Using Specimens from Multi-Institutional Treatment Trials

Kaucic, Karen L, MD
Patterns of Ganglioside Expression in Neuroblastoma
Children's Research Institute, Washington DC

Maris, John M, MD
Significance of Genetic Alterations in Neuroblastoma
Children's Hospital of Philadelphia, Philadelphia, PA

R15 Grants Awarded by CDP in Response to PA 99-062, Academic Research Enhancement Award

Jamasbi, Roudabeh J, PhD
Applicability of mAbs in Diagnosis of Esophageal Cancers
Bowling Green State Univ Bowling Green, Bowling Green, OH

P01 Grants Awarded by CDP in Response to PAR 00-013, Translation of Technologies to Detect Alterations in Human Tumors

Barany, Francis, PhD
New Methods for Cancer Detection
Weill Medical College of Cornell University, New York, NY

R21 Grants Awarded by CDP in Response to PAR 00-079, Improving DNA, RNA and Protein Availability in Fixed Tissue

Jerry, Joseph D, PhD
Profiling Modifications of p53 by Mass Spectrometry
University of Massachusetts Amherst, Amherst, MA

Romano, Louis, J, PhD
New Methods for Tissue Fixation
Wayne State University, Detroit, MI

Umbricht, Christopher B, MD, PhD
Fixation of Breast and Prostate Cancer Tissue
Johns Hopkins University, Baltimore, MD

R21/R33 and R33 Grants Awarded by CDP in Response to PAR 01-061, Phased Application Awards in Cancer Prognosis and Prediction

Bastian, Boris, MD
Classification of Ambiguous Melanocytic Tumors
University of California San Francisco, San Francisco, CA

Bernard, Philip S, MD
Molecular Diagnostics for Breast Cancer
University of Utah, Salt Lake City, UT

Drabkin, Harry A, MD
Quantitative HOX Expression as Prognostic Marker in AML
University of Colorado Health Sciences Center, Denver, CO

Jordan, Richard C, DDS, PhD
Molecular Predictors of Oral Cancer Development
University of California San Francisco, San Francisco, CA

Kees, Ursula R, PhD
Prognosis in Childhood ALL
TVW Telethon Institute-Child Health Research, Subiaco WA, Australia

Lau, Ching C, MD, PhD
Genomic Profile-Based Prognostic Markers for Ependymoma
Baylor College of Medicine, Houston, TX

Sauter, Edward R, MD, PhD
Protein Profiling in Nipple Aspirate Fluid
University of Missouri Columbia, Columbia, MO

Stephan, Dietrich A, PhD
Improved Diagnosis in ALL
Children's Research Institute, Washington DC

Wallace, Michael B, MD
Detection of Occult Mediastinal Lymph Node Metastases
Medical University of South Carolina, Charleston, SC

R21/R33 Grants Awarded by CDP in Response to PAR 01-104, Innovative Technologies for the Molecular Analysis of Cancer: Phased Innovation Award

This Program Announcement (PA) replaces PAR-99-100, which was publishedin the NIH Guide on May 14, 1999.

Heyduk, Tomasz, PhD
Molecular Beacons for Protein Detection
St. Louis University, St. Louis, MO

Larson, Dale, MSME
Protein Localization: Multi-aperture Near-Field Optics
Harvard University (Medical School), Boston, MA

Speicher, David W, PhD
Development of Methods for Cancer Biomarker Detection
Wistar Institute, Philadelphia, PA

Waggoner, Alan S, PhD
Near IR Fluorescent Probes/Molecular Analysis of Cancer
Carnegie-Mellon University, Pittsburgh, PA

Yeung, Edward F, PhD
Single-Molecule Immunoassay and DNA Screening
Iowa State University of Science & Tech, Ames, IA

R43 Grants Awarded by CDP in Response to PAR 01-105, Innovative Technologies for the Molecular Analysis of Cancer: SBIR/STTR

This Program Announcement (PA) replaces PAR-99-101, which was publishedin the NIH Guide on May 14, 1999.

Drees, Beth E, PhD
Phosphoinositide 3-Kinase Assays in Cancer Diagnosis
Echelon Biosciences, Inc., Salt Lake City, UT

Feng, Li, PhD
Lipid Microarrays
Echelon Biosciences, Inc., Salt Lake City, UT

Gau, Vincent J, PhD
Rapid Molecular Detection of PML/RARalpha
Genefluidics, Inc., Monterey, CA

Hancock, Lawrence F, PhD
Polymer Amplified Nucleic Acid Detection
Nomadics, Inc., Cambridge, MA

Hanna, Michelle M, PhD
Rapid Analysis of CpG Methylation Changes in Cancer
Designer Genes, Inc., Phoenix, AZ

Israel, Barbara A, PhD
Obliquely Deposited Substrates for Detection of Ras
Platypus Technologies, LLC, Madison, WI

Latham, Gary J, PhD
Enzymatic Tools for Degrading Tissue and Preserving RNA
Ambion, Inc., Austin, TX

Loge, Gary W, PhD
An Automated 2D-Capillary Electrophoresis System
Spectrumedix Corporation, State College, PA

Martin, Mark T, PhD
Microwave-Enhanced Luminescence to Detect Growth Factors
Mirari Biosciences, Inc., Rockville, MD

Yang, Xing, PhD
Multiplexed DNA-Mediated Electochemical Sensors
GeneOhm Sciences, Inc., San Diego, CA

R21/R33 and R33 Grants Awarded by CDP in Response to PAR 01-106, Applications of Innovative Technologies for the Molecular Analysis of Cancer: Phased Innovation Award

This Program Announcement (PA) replaces PAR-99-102, which was publishedin the NIH Guide on May 14, 1999.

Baker, Laurence H, DO
Molecular Diagnosis of Sarcomas
University of Michigan at Ann Arbor, Ann Arbor, MI

Chuong, Cheng-Ming, MD, PhD
High Resolution Microarray Analysis of Cancer
University of Southern California, Los Angeles, CA

Dynan, William S, PhD
Laser Capture Microscopy and 2D-DIGE: Cancer Proteomics
Medical College of Georgia, Augusta, GA

Levenson, Victor V, MD, PhD
DNA Methylation in Patients with Non-Hodgkin's Lymphoma
Northwestern University, Chicago, IL

Shaughnessy, John D, PhD
Molecular Diagnosis and Prognosis of Multiple Myeloma
University of Arkansas for Medical Sciences Little Rock, Little Rock, AR

R43 Grants Awarded by CDP in Response to PAR 01-107, Applications of Innovative Technologies for the Molecular Analysis of Cancer: SBIR/STTR

This Program Announcement (PA) replaces PAR-99-103, which was publishedin the NIH Guide on May 14, 1999.

Tang, Cha-Mei, ScD
Development of a Cancer Specific PCNA Tumor Marker Immunosensor
Creatv MicroTech, Inc., Potomac, MD

R21/R33 and R33 Grants Awarded by CDP in Response to PAR 99-100, Innovative Technologies for the Molecular Analysis of Cancer: Phased Innovation Award (R21/R33)

This PA is a reissuance of PAR-98-067, which was published in the NIH Guide on May 8, 1998.

Futscher, Bernard W, PhD
Microarray Technology to Profile CpG Island Methylation
University of Arizona, Tucson, AZ

Issa, Jean-Pierre J, MD
Neoplasia and Methylated CpG Islands Amplification
University of Texas MD Anderson Cancer Center, Houston, TX

Mayer, Bruce J, PhD
Profiling Tumor Cells by SH2 Domain Binding Pattern
University of Connecticut Sch of Med/Dnt, Farmington, CT

R43 and R44 Grants Awarded by CDP in Response to PAR 99-101, Innovative Technologies for the Molecular Analysis of Cancer: SBIR/STTR Initiative

This PA is a reissuance of PAR-98-066, which was published in the NIH Guide on May 8, 1998.

Henkens, Robert W, PhD
Innovative Technology for Gene Expression Studies
Alderon Biosciences, Beaufort, NC

Zebala, John A, MD, PhD
Light-Up PNA Arrays
Syntrix Biosystems, Inc., Sammamish, WA

Section Last Updated: 07/24/07